netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 10: Musculoskeletal and joint diseases - Full Chapter
10.03.02  Expand sub section  Rubefacients, topical NSAIDs, capsaicin, and poultices
 note 

Rubefacients (excluding topical NSAIDs) should NOT be routinely prescribed in Primary Care and are NON-FORMULARY. 

This is in line with NHS England's Guidance, see link below: 

10.03.02  Expand sub section  Topical NSAIDs and counter-irritants
Ibuprofen gel
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
10.03.02  Expand sub section  Capsaicin
10.03.02  Expand sub section  Poultices
 ....
 Non Formulary Items
Algesal

View adult BNF View SPC online View childrens BNF
Non Formulary
Black
Link  Patient Information Leaflet
 
Diclofenac  (Mobigel®, Voltarol Emugel®, Voltarol Gel Patch®, Pennsaid)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black
 
Felbinac  (Traxam®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ketoprofen 2.5%  (Oruvail ®, Powergel®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Movelat  (Topical gel / cream)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black
Link  Patient Information Leaflet
 
Piroxicam  (Feldene®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black
 
Transvasin

View adult BNF View SPC online View childrens BNF
Non Formulary
Black
Link  Patient Information Leaflet
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Prescribing in children

The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.

  

Green

Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

Amber

Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

Red

Medicines for initiation and maintenance prescribing by Specialists only  

Black

Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

Grey

Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

netFormulary